Aparna Raval

2.0k total citations
37 papers, 1.0k citations indexed

About

Aparna Raval is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Aparna Raval has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Genetics. Recurrent topics in Aparna Raval's work include Chronic Lymphocytic Leukemia Research (9 papers), Epigenetics and DNA Methylation (7 papers) and RNA modifications and cancer (7 papers). Aparna Raval is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Epigenetics and DNA Methylation (7 papers) and RNA modifications and cancer (7 papers). Aparna Raval collaborates with scholars based in United States, Switzerland and India. Aparna Raval's co-authors include Christoph Plass, Dinah S. Singer, Jocelyn D. Weissman, Laura Z. Rassenti, John C. Byrd, T. Kevin Howcroft, Beverly S. Mitchell, Sandya Liyanarachchi, Shih-Shih Chen and John C. Byrd and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Aparna Raval

37 papers receiving 1.0k citations

Peers

Aparna Raval
Erich Piovan Italy
Holger Kohlhammer Germany
Matt Teater United States
Vladimir Trifonov United States
Michela Frenquelli Italy
Mark Y. Chiang United States
E Nacheva United Kingdom
Nicholas Burwick United States
C M Croce United States
Lara Rizzotto Italy
Erich Piovan Italy
Aparna Raval
Citations per year, relative to Aparna Raval Aparna Raval (= 1×) peers Erich Piovan

Countries citing papers authored by Aparna Raval

Since Specialization
Citations

This map shows the geographic impact of Aparna Raval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aparna Raval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aparna Raval more than expected).

Fields of papers citing papers by Aparna Raval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aparna Raval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aparna Raval. The network helps show where Aparna Raval may publish in the future.

Co-authorship network of co-authors of Aparna Raval

This figure shows the co-authorship network connecting the top 25 collaborators of Aparna Raval. A scholar is included among the top collaborators of Aparna Raval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aparna Raval. Aparna Raval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Sandy W., Habib Hamidi, Luciano J. Costa, et al.. (2023). Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM. Frontiers in Immunology. 14. 1085893–1085893. 3 indexed citations
2.
Palomba, M. Lia, Brian G. Till, Steven I. Park, et al.. (2021). Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B‐Cell Lymphoma: Results from a Phase 1b Study. Clinical Lymphoma Myeloma & Leukemia. 22(7). e443–e451. 13 indexed citations
3.
Cho, Hearn Jay, Sandy W. Wong, Aparna Raval, et al.. (2021). P-071: Multi-omic analysis of the tumor microenvironment reveals novel associations in a clinical trial of atezolizumab ± daratumumab for relapsed/refractory multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 21. S78–S78. 1 indexed citations
4.
5.
6.
Nguyen, Le Xuan Truong, et al.. (2014). Regulation of Ribosomal Gene Expression in Cancer. Journal of Cellular Physiology. 230(6). 1181–1188. 40 indexed citations
7.
Nguyen, Le Xuan Truong, Steven M. Chan, Aparna Raval, et al.. (2014). Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cells. Blood. 124(4). 579–589. 16 indexed citations
8.
Claus, Rainer, Thomas Hielscher, Daniel Mertens, et al.. (2013). Germline Allele-Specific Expression of DAPK1 in Chronic Lymphocytic Leukemia. PLoS ONE. 8(1). e55261–e55261. 20 indexed citations
9.
Raval, Aparna, Christopher Y. Park, Wendy W. Pang, et al.. (2009). NPM1 Haploinsufficiency Results in Increased Numbers of Hematopoietic Stem Cells and Progenitor Cells.. Blood. 114(22). 738–738. 2 indexed citations
10.
Opavský, René, Shu‐Huei Wang, Prashant Trikha, et al.. (2007). CpG Island Methylation in a Mouse Model of Lymphoma Is Driven by the Genetic Configuration of Tumor Cells. PLoS Genetics. 3(9). e167–e167. 34 indexed citations
11.
Plass, Christoph, John C. Byrd, Aparna Raval, Stephan M. Tanner, & Albert de la Chapelle. (2007). Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes. British Journal of Haematology. 139(5). 744–752. 17 indexed citations
12.
Raval, Aparna, et al.. (2006). CpG Island Methylation and Expression of the Secreted Frizzled-Related Protein Gene Family in Chronic Lymphocytic Leukemia. Cancer Research. 66(2). 653–658. 100 indexed citations
13.
Yu, Li‐Rong, Jeffrey VanDeusen, Brian Becknell, et al.. (2005). Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nature Genetics. 37(3). 265–274. 129 indexed citations
14.
Dai, Zunyan, Anthony P. Popkie, Wei‐Guo Zhu, et al.. (2004). Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. Oncogene. 23(20). 3521–3529. 49 indexed citations
15.
Yu, Li, Chunhui Liu, Kristi L. Bennett, et al.. (2004). A NotI–EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. Genomics. 84(4). 647–660. 20 indexed citations
16.
Howcroft, T. Kevin, Aparna Raval, Jocelyn D. Weissman, Anne Gégonne, & Dinah S. Singer. (2003). Distinct Transcriptional Pathways Regulate Basal and Activated Major Histocompatibility Complex Class I Expression. Molecular and Cellular Biology. 23(10). 3377–3391. 35 indexed citations
17.
Weissman, Jocelyn D., Aparna Raval, & Dinah S. Singer. (2003). Assay of an Intrinsic Acetyltransferase Activity of the Transcriptional Coactivator CIITA. Methods in enzymology on CD-ROM/Methods in enzymology. 370. 378–386. 8 indexed citations
18.
Dai, Zunyan, Dieter Weichenhan, Yue-Zhong Wu, et al.. (2002). An AscI Boundary Library for the Studies of Genetic and Epigenetic Alterations in CpG Islands. Genome Research. 12(10). 1591–1598. 16 indexed citations
19.
Raval, Aparna, T. Kevin Howcroft, Jocelyn D. Weissman, et al.. (2001). Transcriptional Coactivator, CIITA, Is an Acetyltransferase that Bypasses a Promoter Requirement for TAFII250. Molecular Cell. 7(1). 105–115. 98 indexed citations
20.
Raval, Aparna, Niti Puri, Poonam Rath, & Rajiv K. Saxena. (1998). Cytokine regulation of expression of class I MHC antigens. Experimental & Molecular Medicine. 30(1). 1–13. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erich Piovan Breakdown of academic impact, for papers by Holger Kohlhammer Breakdown of academic impact, for papers by Matt Teater Breakdown of academic impact, for papers by Vladimir Trifonov Breakdown of academic impact, for papers by Michela Frenquelli Breakdown of academic impact, for papers by Mark Y. Chiang Breakdown of academic impact, for papers by E Nacheva Breakdown of academic impact, for papers by Nicholas Burwick Breakdown of academic impact, for papers by C M Croce Breakdown of academic impact, for papers by Lara Rizzotto
Rankless by CCL
2026